M.D. Anderson Cancer Center: Neoplasms trials

The registry lists 278 Neoplasms studies with M.D. Anderson Cancer Center as lead sponsor. 35 are open to participants now and 54 have results posted.

Early Phase 1 7Phase 1 102Phase 2 62Phase 3 16Phase 4 4No phase 106(a study in two phases counts in both)

Studies

Page 3 of 3. Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Erlotinib in Combination With Pralatrexate in Advanced MalignanciesCompletedNCT01532011Phase 1
• Vemurafenib With Sorafenib Tosylate or Crizotinib in Treating Patients With Advanced Malignancies With BRAF MutationsCompletedNCT01531361Phase 1
• Temsirolimus in Combination With Metformin in Patients With Advanced CancersTerminatedNCT01529593Phase 1
• BiPAP-Vapotherm RCTWithdrawnNCT01518140Phase 2
• Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic MalignanciesCompletedNCT01471067Phase 1
• The Role of the EKG in Anticancer Drug DevelopmentCompletedNCT01462383
• Vorinostat With Gemcitabine, Busulfan, and Melphalan With Stem Cell Transplant (SCT) in Relapsed or Refractory Lymphoid MalignanciesCompletedNCT01421173Phase 1
• Study of Pazopanib and Vorinostat in Patients With Advanced MalignanciesCompletedNCT01339871Phase 1
• Sirolimus or Vorinostat and Hydroxychloroquine in Advanced CancerCompletedNCT01266057Phase 1
• Hepatic Arterial Infusion Oxaliplatin, Capecitabine With or Without BevacizumabCompletedNCT01213238Phase 1
• Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)CompletedNCT01183663Phase 1
• Trientine and Carboplatin in Advanced MalignanciesCompletedNCT01178112Phase 1
• Bendamustine and Bevacizumab for Advanced CancersCompletedNCT01152203Phase 1
• 4'-Thio-araC (Thiarabine) in Advanced Hematologic MalignanciesCompletedNCT01139151Phase 1
• Nab-paclitaxel, Gemcitabine, and Bevacizumab in Advanced MalignanciesCompletedNCT01113476Phase 1
• Antimicrobial Solution or Saline Solution in Maintaining Catheter Patency and Preventing Catheter-Related Blood Infections in Patients With MalignanciesWithdrawnNCT01101412Phase 1/2
• Smoking Cessation Treatment for Head & Neck Cancer PatientsActive, not recruitingNCT01098955Early Phase 1
• Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Nelarabine in Patients With Relapsed/Refractory Lymphoid MalignanciesCompletedNCT01094860Phase 1
• Lapatinib With Sirolimus or MetforminCompletedNCT01087983Phase 1
• HAI Abraxane With Gemcitabine and BevacizumabCompletedNCT01057264Phase 1
• Docetaxel and Sirolimus in Patients With Advanced MalignanciesCompletedNCT01054313Phase 1
• Comparison of PEM Uptake Value (PUV) and Standardized Uptake Value (SUV) in Patients With Malignancies of the BreastCompletedNCT01031238
• Detection of Cervical Lymph Node Metastases With a High-Resolution Positron Emission Tomography (PET) Imaging SystemCompletedNCT01030497
• Dasatinib, Bevacizumab, Paclitaxel in Patients With Advanced MalignanciesCompletedNCT01015222Phase 1
• Feasibility Study for Imaging of Peripheral Tumors With a High-Resolution PET Imaging SystemCompletedNCT01008930Not applicable
• Motivational Interviewing for Physical ActivityActive, not recruitingNCT01008787Not applicable
• HAI Irinotecan + IV Bevacizumab, Bevacizumab & Oxaliplatin or Bevacizumab & Cetuximab in Advanced Cancers Metastatic to LiverCompletedNCT00980239Phase 1
• CD19-specific T Cell Infusion in Patients With B-Lineage Lymphoid MalignanciesCompletedNCT00968760Phase 1
• STAT3 Inhibitor for Solid TumorsCompletedNCT00955812Phase 1
• Hepatic Arterial Infusion Oxaliplatin + 5FU, Leucovorin, and Bevacizumab +/- CetuximabCompletedNCT00941499Phase 1
• Sirolimus and Cetuximab in Advanced MalignanciesCompletedNCT00940381Phase 1
• TTP607 in Refractory Solid MalignanciesWithdrawnNCT00939172Phase 1
• LY2275796 in Advanced CancerCompletedNCT00903708Phase 1
• Study of Erlotinib in Combination With BortezomibCompletedNCT00895687Phase 1
• Erlotinib in Combination With CetuximabCompletedNCT00895362Phase 1
• Study of Erlotinib in Combination With DasatinibCompletedNCT00895128Phase 1
• FLT-PET in Predicting Response to Chemotherapy in Patients With Advanced MalignanciesCompletedNCT00880074Phase 1
• 4D PET/CT in Diagnosing Participants With Lung and Colorectal Cancer With Liver and Lung MetastasisCompletedNCT00862680
• Initiative for Molecular Profiling in Advanced Cancer Therapy (IMPACT) Trial, An Umbrella ProtocolStatus unknownNCT00851032
• Sodium Stibogluconate With Interferon Alpha-2b for Patients With Advanced MalignanciesCompletedNCT00629200Phase 1
• Interactive Voice Response System in Advanced Cancer PatientsCompletedNCT00625638Not applicable
• Bevacizumab and Temsirolimus in Patients With Advanced MalignancyCompletedNCT00610493Phase 1
• Education Intervention in Encouraging Health Providers to Talk With Cancer Patients About the Use of Complementary and Alternative MedicineCompletedNCT00608933Phase 3
• Cardiac Biomarkers in Early Detection of Cardiotoxicity in Patients Receiving Sunitinib or Sorafenib ChemotherapyTerminatedNCT00532064
• 4-Dimensional CT Derived Ventilation Versus SPECT Aerosol Ventilation in Patients With Thoracic MalignanciesCompletedNCT00531180Phase 2
• Valproic Acid and Bevacizumab in Patients With Advanced CancerCompletedNCT00530907Phase 1
• Cloretazine (VNP40101M) With Hematopoietic Cell Transplantation for Hematologic MalignanciesCompletedNCT00521859Phase 1
• Measurement of Digital Colposcopy for Fluorescence Spectroscopy of Cervical Intraepithelial NeoplasiaCompletedNCT00513123
• RTA 744 Injection in Patients With Leptomeningeal DiseaseTerminatedNCT00512460Phase 1
• Molecular Imaging for Detection of Cervical Intraepithelial NeoplasiaCompletedNCT00511615
• Doxercalciferol in Recurrent Pediatric Solid TumorsTerminatedNCT00511017Phase 1
• Phase I Trial of ZIO-101 in Patients With Solid TumorsCompletedNCT00509782Phase 1
• RTA 402 in Advanced Solid Tumors or Lymphoid MalignanciesCompletedNCT00508807Phase 1
• Evaluation of a Novel CT-On-Rails or Trilogy Stereotactic Spine Radiotherapy System (SSRS)Active, not recruitingNCT00508443Phase 1/2
• Paclitaxel Administered by HAI to Patients With Advanced Cancer and Dominant Liver InvolvementCompletedNCT00508326Phase 1
• Cisplatin HAI Study in Patients With Advanced Cancer and Dominant Liver InvolvementCompletedNCT00507962Phase 1
• Measurement of Digital Colposcopy for Fluorescence Spectroscopy of TNC Using a Second DeviceWithdrawnNCT00503919Phase 1
• Topotecan, Ifosfamide and Carboplatin in Children and Young Adults With Solid TumorsCompletedNCT00502892Phase 1
• Psychosocial Aspects of Multiple Endocrine Neoplasia (MEN) SyndromesCompletedNCT00501449
• Azacytidine and Valproic Acid in Patients With Advanced CancersCompletedNCT00496444Phase 1
• Valproic Acid-Based 2-Agent Oral Regimens for Patients With Advanced Solid TumorCompletedNCT00495872Phase 1
• Delirium Recall in Advanced Cancer PatientsCompletedNCT00493714
• Olanzapine in Patients With Advanced Cancer and Weight LossCompletedNCT00489593Phase 1
• Nuclear Imaging of Human CSF Flow Using Ga-67 Citrate and In-111 DTPATerminatedNCT00477503Phase 1
• Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin for Children With Peritoneal CancerCompletedNCT00436657Phase 1
• Study of Atiprimod Treatment for Patients With Advanced CancerTerminatedNCT00430014Phase 1
• Gemcitabine and Dasatinib in Advanced Solid TumorsCompletedNCT00429234Phase 1
• Bevacizumab and Bortezomib in Patients With Advanced MalignancyCompletedNCT00428545Phase 1
• Gemcitabine Plus Busulfan, Melphalan and Hematopoietic Cell Transplant for Advanced Lymphoid MalignanciesCompletedNCT00410982Phase 1
• Alpha-Lipoic Acid in Preventing Peripheral Neuropathy in Patients Receiving Chemotherapy for CancerCompletedNCT00112996Phase 3
• Phase I Study of Continuous Infusion Schedule of FMdC in Hematologic MalignanciesCompletedNCT00061620Phase 1
• Study of ABT-751 in Patients With Refractory Hematologic MalignanciesCompletedNCT00047489Phase 1
• IUdR/BUdR Cell Cycle LabellingCompletedNCT00042250Not applicable
• Campath-1H and Allogeneic Blood Stem Cell Transplantation for Lymphoid MalignanciesTerminatedNCT00038883Not applicable
• Phase II Study Of Roferon and Accutane For Patients With T-Cell MalignanciesCompletedNCT00038376Phase 2
• Assessment of Head and Neck Tumor Hypoxia Using 18F-FluoromisonidazoleWithdrawnNCT00038038Not applicable
• Safety, Efficacy and Pharmacokinetic Between Capecitabine and Exisulind in Metastatic Breast Cancer PatientsCompletedNCT00037609Phase 1/2
• Fenretinide in Treating Patients With Cervical NeoplasiaCompletedNCT00003075Phase 3